Advanced Search

    Technical Analysis for EMMLF - Okyo Pharma Ltd

    Grade Last Price % Change Price Change
    C 0.0203 -32.78% -0.0099
    EMMLF closed down 32.78 percent on Friday, March 17, 2023, on 25 percent of normal volume. The bears made the stock sink to a new 52-week low.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A N/A N/A
    Historical EMMLF trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    Narrow Range Bar Range Contraction 0.00%
    New 52 Week Low Weakness 0.00%
    Gapped Down Weakness 0.00%
    Narrow Range Bar Range Contraction -32.78%
    Gapped Up Strength -32.78%
    New 52 Week Closing Low Bearish -19.44%
    Hot IPO Pullback Bullish Swing Setup -19.44%
    Narrow Range Bar Range Contraction -19.44%
    New 52 Week Low Weakness -19.44%
    Older End-of-Day Signals for EMMLF ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators Basic chart:

    Profile

    OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
    Classification
    Keywords: Drugs Psychoactive Drugs Pain Neurochemistry Amines Ketamine

    Is EMMLF a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 0 bearish and 5 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 16 OKYO Pharma Announces Phase 2 Trial of OK-101 Drug to Treat Dry Eye Disease is now listed on the ClinicalTrials.gov Public Website
    Mar 14 OKYO Pharma Limited announces U.S.$5.74 million Global Private Placement and investment by directors and members of senior management
    Mar 13 OKYO Pharma Limited Prices $5.3 Million Offering of ADSs
    Mar 10 SmallCapsDaily Interviews OKYO Pharma CEO Dr. Gary Jacob, PHD
    See more EMMLF news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.0835
    52 Week Low 0.0203
    Average Volume 4,040
    200-Day Moving Average 0.0000
    50-Day Moving Average 0.0000
    20-Day Moving Average 0.0000
    10-Day Moving Average 0.0000
    Average True Range 0.0000
    RSI 0.00
    ADX 0.0
    +DI 0.0000
    -DI 0.0000
    Chandelier Exit (Long, 3 ATRs) N/A
    Chandelier Exit (Short, 3 ATRs) N/A
    Upper Bollinger Bands 0.0000
    Lower Bollinger Band 0.0000
    Percent B (%b) 0.0
    BandWidth 0.0000
    MACD Line 0.0000
    MACD Signal Line 0.0000
    MACD Histogram 0.0
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.0203
    Resistance 3 (R3) 0.0203 0.0203 0.0203
    Resistance 2 (R2) 0.0203 0.0203 0.0203 0.0203
    Resistance 1 (R1) 0.0203 0.0203 0.0203 0.0203 0.0203
    Pivot Point 0.0203 0.0203 0.0203 0.0203 0.0203
    Support 1 (S1) 0.0203 0.0203 0.0203 0.0203 0.0203
    Support 2 (S2) 0.0203 0.0203 0.0203 0.0203
    Support 3 (S3) 0.0203 0.0203 0.0203
    Support 4 (S4) 0.0203